What's Happening?
Neko Health, a body-scanning and health assessment startup founded by Spotify's Daniel Ek and Hjalmar Nilsonne, has raised $700 million in a Series C funding round. The round was led by Lightspeed Venture Partners and O.G. Venture Partners, following
a $260 million Series B in January 2025. Neko Health's technology combines body scans with bloodwork to assess health, and it integrates with Apple Health data for comprehensive assessments. The company plans to open its first U.S. location in New York, with over 100,000 scans already conducted and 350,000 people on the waitlist.
Why It's Important?
Neko Health's significant funding round underscores the growing interest in health technology and personalized medicine. The company's expansion into the U.S. market could revolutionize how health assessments are conducted, offering more accessible and comprehensive health data to individuals. This development could lead to earlier detection of health issues, as evidenced by a case where a scan identified a malignant mole on a user. The integration of technology in health assessments represents a shift towards more data-driven and personalized healthcare solutions, potentially improving health outcomes and reducing healthcare costs.
What's Next?
With the new funding, Neko Health is poised to expand its operations and technology offerings. The opening of its first U.S. location in New York marks a significant step in its global expansion strategy. As the company grows, it may face competition from other tech-driven health startups, such as Midjourney, which is also developing a body scanner. The success of Neko Health's U.S. launch could influence the broader adoption of body-scanning technology in healthcare, prompting further innovation and investment in the sector.
